FDA has accepted Genetech application for obinutuzumab (Gazyva) to treat SLE (currently only approved for lupus nephritis) - based on Phase III ALLEGORY study w/ Gazyva showing signif reduced dz activity https://t.co/hgYMJJDKGA https://t.co/41sZkXPM7W

DESIR axSpA inception cohort study of 631 pts (no HTN), found no signif association between NSAID use & incident HTN. Over 10 YRs, 88 developed HTN (HR 1.01, 1.00–1.02) https://t.co/Gs9mPwthEj https://t.co/4sfpHmFTsu

Chinese study of 371 pts w/ Autoimmune hepatitis (AIH) - extrahepatic autoimmune diseases (EADs) seen in 24% -Sjogren’s & autoimmune thyroid dz (9% each). ANA+ independently assoc w/ EADs (OR 2) https://t.co/NVz8MWbJch https://t.co/tjCzaDcUFI

Comorbidity burden, uveitis, & psoriasis independently assoc w/ greater spinal radiographic progression in AS. Study3,441 pts (75% male; 84% B27+). Progression greater w/ 2+ comorbidities & uveitis, & PSO https://t.co/WDUdjqiD4e https://t.co/nkRCjzSLFT

Chinese target emulation trial of MDA-5+, dermatomyositis w/ ILD. 106 Rx w/ UPA & 328 w/ TOFA. 6-month lung transplantation-free survival 72% vs 67% (UPA v TOFA). UPA non-inferior to TOFA in MDA5+DM-ILD https://t.co/BBAfbM06AM https://t.co/QP8YdX7CcH

Ensayo chino de emulación de diana de MDA-5+, dermatomiositis con EPI. 106 trat. con UPA & 328 con TOFA. Supervivencia libre de trasplante pulmonar a 6 meses 72% vs 67% (UPA vs TOFA). UPA no inferior a TOFA en DM-EPI MDA5+ https://t.co/BBAfbM06AM https://t.co/QP8YdX7CcH

Rheumatology Salaries 2025 Medscape has published its annual Physician Compensation report with physican salaries up roughly 3% and eight specialties earning more than $500,000 per annum. https://t.co/UKc2l4FBQZ https://t.co/Kqzbl6pGWh

Salarios de Reumatología 2025 Medscape ha publicado su informe anual de Compensación Médica con salarios de médicos aumentando aproximadamente un 3% y ocho especialidades ganando más de $500,000 al año. https://t.co/UKc2l4FBQZ https://t.co/Kqzbl6pGWh

Prescribing Lessons (4.17.2026) https://t.co/6JfMvsGIdS https://t.co/W6BNcwMD3O

Aspirin Cardiovascular Prevention in Giant Cell Arteritis A retrospective target trial emulations has shown that low-dose aspirin (ASA) given with a giant cell arteritis (GCA) diagnosis is associated with a lower risk of major adverse cardiovascular events (MACE), but a higher https://t.co/dpGzjKZYkA

Weight-loss drugs may affect joints directly A new study from Aarhus University shows that the hormone GLP-1, which is mimicked in medication for diabetes and weight loss, is present in joint fluid. In the long term, this may open up new treatments for arthritis. https://t.co/xKm8Ng7fXO